Serum Cystatin C as an Indicator of Renal Function and Mortality in Liver Transplant Recipients

Alina Allen, W. Ray Kim, Joseph J. Larson, Colin Colby, Terry M Therneau, Andrew D Rule

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Chronic kidney disease (CKD) is an important comorbidity after liver transplantation (LT); however, reliable tools with which to evaluate these patients are limited. In this work, we examine the extent to which the addition of serum cystatin C improves glomerular filtration rate (GFR) estimation and mortality prediction, in comparison to various GFR-estimating equations. Methods The GFR was measured in LT recipients by iothalamate clearance. Concurrent serum cystatin C was assayed in banked serum samples. Performance of GFR-estimating equations with and without cystatin C, including the modification of diet in renal disease and CKD-epidemiology collaboration formulas was assessed. The proportional hazards regression analysis was performed to determine the association between serum cystatin C and mortality. Results A total of 586 iothalamate results were obtained in 401 patients after a mean of 4 years after LT. When compared to measured GFR, the formula with both creatinine and cystatin C, namely, CKD-epidemiology cr-cys, outperformed those with either marker alone. Performance of creatinine-based models was similar to one another. Serum cystatin C, by itself or as a part of an estimated GFR, was a significant predictor of mortality. Conclusions Serum cystatin C has an important role in enhancing accuracy of GFR estimation and predicting mortality in LT recipients.

Original languageEnglish (US)
Pages (from-to)1431-1435
Number of pages5
JournalTransplantation
Volume99
Issue number7
DOIs
StatePublished - Jul 2 2015

Fingerprint

Cystatin C
Glomerular Filtration Rate
Kidney
Mortality
Liver
Liver Transplantation
Serum
Chronic Renal Insufficiency
Iothalamic Acid
Creatinine
Epidemiology
Diet Therapy
Transplant Recipients
Comorbidity
Regression Analysis

ASJC Scopus subject areas

  • Transplantation

Cite this

Serum Cystatin C as an Indicator of Renal Function and Mortality in Liver Transplant Recipients. / Allen, Alina; Kim, W. Ray; Larson, Joseph J.; Colby, Colin; Therneau, Terry M; Rule, Andrew D.

In: Transplantation, Vol. 99, No. 7, 02.07.2015, p. 1431-1435.

Research output: Contribution to journalArticle

@article{b55b912f32b6460484a30a800629e27d,
title = "Serum Cystatin C as an Indicator of Renal Function and Mortality in Liver Transplant Recipients",
abstract = "Chronic kidney disease (CKD) is an important comorbidity after liver transplantation (LT); however, reliable tools with which to evaluate these patients are limited. In this work, we examine the extent to which the addition of serum cystatin C improves glomerular filtration rate (GFR) estimation and mortality prediction, in comparison to various GFR-estimating equations. Methods The GFR was measured in LT recipients by iothalamate clearance. Concurrent serum cystatin C was assayed in banked serum samples. Performance of GFR-estimating equations with and without cystatin C, including the modification of diet in renal disease and CKD-epidemiology collaboration formulas was assessed. The proportional hazards regression analysis was performed to determine the association between serum cystatin C and mortality. Results A total of 586 iothalamate results were obtained in 401 patients after a mean of 4 years after LT. When compared to measured GFR, the formula with both creatinine and cystatin C, namely, CKD-epidemiology cr-cys, outperformed those with either marker alone. Performance of creatinine-based models was similar to one another. Serum cystatin C, by itself or as a part of an estimated GFR, was a significant predictor of mortality. Conclusions Serum cystatin C has an important role in enhancing accuracy of GFR estimation and predicting mortality in LT recipients.",
author = "Alina Allen and Kim, {W. Ray} and Larson, {Joseph J.} and Colin Colby and Therneau, {Terry M} and Rule, {Andrew D}",
year = "2015",
month = "7",
day = "2",
doi = "10.1097/TP.0000000000000552",
language = "English (US)",
volume = "99",
pages = "1431--1435",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Serum Cystatin C as an Indicator of Renal Function and Mortality in Liver Transplant Recipients

AU - Allen, Alina

AU - Kim, W. Ray

AU - Larson, Joseph J.

AU - Colby, Colin

AU - Therneau, Terry M

AU - Rule, Andrew D

PY - 2015/7/2

Y1 - 2015/7/2

N2 - Chronic kidney disease (CKD) is an important comorbidity after liver transplantation (LT); however, reliable tools with which to evaluate these patients are limited. In this work, we examine the extent to which the addition of serum cystatin C improves glomerular filtration rate (GFR) estimation and mortality prediction, in comparison to various GFR-estimating equations. Methods The GFR was measured in LT recipients by iothalamate clearance. Concurrent serum cystatin C was assayed in banked serum samples. Performance of GFR-estimating equations with and without cystatin C, including the modification of diet in renal disease and CKD-epidemiology collaboration formulas was assessed. The proportional hazards regression analysis was performed to determine the association between serum cystatin C and mortality. Results A total of 586 iothalamate results were obtained in 401 patients after a mean of 4 years after LT. When compared to measured GFR, the formula with both creatinine and cystatin C, namely, CKD-epidemiology cr-cys, outperformed those with either marker alone. Performance of creatinine-based models was similar to one another. Serum cystatin C, by itself or as a part of an estimated GFR, was a significant predictor of mortality. Conclusions Serum cystatin C has an important role in enhancing accuracy of GFR estimation and predicting mortality in LT recipients.

AB - Chronic kidney disease (CKD) is an important comorbidity after liver transplantation (LT); however, reliable tools with which to evaluate these patients are limited. In this work, we examine the extent to which the addition of serum cystatin C improves glomerular filtration rate (GFR) estimation and mortality prediction, in comparison to various GFR-estimating equations. Methods The GFR was measured in LT recipients by iothalamate clearance. Concurrent serum cystatin C was assayed in banked serum samples. Performance of GFR-estimating equations with and without cystatin C, including the modification of diet in renal disease and CKD-epidemiology collaboration formulas was assessed. The proportional hazards regression analysis was performed to determine the association between serum cystatin C and mortality. Results A total of 586 iothalamate results were obtained in 401 patients after a mean of 4 years after LT. When compared to measured GFR, the formula with both creatinine and cystatin C, namely, CKD-epidemiology cr-cys, outperformed those with either marker alone. Performance of creatinine-based models was similar to one another. Serum cystatin C, by itself or as a part of an estimated GFR, was a significant predictor of mortality. Conclusions Serum cystatin C has an important role in enhancing accuracy of GFR estimation and predicting mortality in LT recipients.

UR - http://www.scopus.com/inward/record.url?scp=84928348405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928348405&partnerID=8YFLogxK

U2 - 10.1097/TP.0000000000000552

DO - 10.1097/TP.0000000000000552

M3 - Article

C2 - 25654627

AN - SCOPUS:84928348405

VL - 99

SP - 1431

EP - 1435

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 7

ER -